Search Results - "Gogas, K R"

Refine Results
  1. 1

    Central infusion of the melanocortin receptor antagonist agouti-related peptide (AgRP(83-132)) prevents cachexia-related symptoms induced by radiation and colon-26 tumors in mice by Joppa, M.A., Gogas, K.R., Foster, A.C., Markison, S.

    Published in Peptides (New York, N.Y. : 1980) (01-03-2007)
    “…Cachexia is a clinical wasting syndrome that occurs in multiple disease states, and is associated with anorexia and a progressive loss of body fat and lean…”
    Get full text
    Journal Article
  2. 2

    Central administration of peptide and small molecule MC4 receptor antagonists induce hyperphagia in mice and attenuate cytokine-induced anorexia by Joppa, M.A., Ling, N., Chen, C., Gogas, K.R., Foster, A.C., Markison, S.

    Published in Peptides (New York, N.Y. : 1980) (01-11-2005)
    “…We investigated the effect of melanocortin 4 receptor (MC4) antagonists on food intake in mice. Food intake during the light phase was significantly increased…”
    Get full text
    Journal Article
  3. 3

    The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain by Hunter, John C., Gogas, Kathleen R., Hedley, Linda R., Jacobson, Lupita O., Kassotakis, Laura, Thompson, Julie, Fontana, David J.

    Published in European journal of pharmacology (01-04-1997)
    “…The novel anti-epileptic drugs lamotrigine, felbamate and gabapentin were compared in rat experimental models of acute (tail flick) and chronic pain: the…”
    Get full text
    Journal Article
  4. 4

    Glutamate-based therapeutic approaches: NR2B receptor antagonists by Gogas, Kathleen R

    Published in Current opinion in pharmacology (01-02-2006)
    “…Over the past decade, there have been major advances in our understanding of the role of glutamate and N-methyl- d-aspartate (NMDA) receptors in several…”
    Get full text
    Journal Article
  5. 5

    Inhibition of noxious stimulus-evoked pain behaviors and neuronal fos-like immunoreactivity in the spinal cord of the rat by supraspinal morphine by Gogas, K R, Cho, H J, Botchkina, G I, Levine, J D, Basbaum, A I

    Published in Pain (Amsterdam) (01-04-1996)
    “…In previous studies, we reported that supraspinally administered DAMGO, a mu-opioid agonist, produces a dose-related, naloxone-reversible inhibition of…”
    Get more information
    Journal Article
  6. 6

    Walking evokes a distinctive pattern of Fos-like immunoreactivity in the caudal brainstem and spinal cord of the rat by Jasmin, L, Gogas, K R, Ahlgren, S C, Levine, J D, Basbaum, A I

    Published in Neuroscience (01-01-1994)
    “…We have evaluated the pattern of c-fos expression induced in the rat spinal cord, caudal brainstem and cerebellum by a behavior that is associated with…”
    Get more information
    Journal Article
  7. 7

    Morphine or U-50,488 suppresses Fos protein-like immunoreactivity in the spinal cord and nucleus tractus solitarii evoked by a noxious visceral stimulus in the rat by Hammond, D L, Presley, R, Gogas, K R, Basbaum, A I

    Published in Journal of comparative neurology (1911) (08-01-1992)
    “…Immunohistochemical visualization of Fos protein, the nuclear phosphoprotein product of the early-immediate gene c-fos, permits identification of populations…”
    Get more information
    Journal Article
  8. 8

    Differential contribution of descending controls to the antinociceptive actions of kappa and mu opioids: an analysis of formalin-evoked C-fos expression by Gogas, K R, Levine, J D, Basbaum, A I

    “…In this study, the effect of intracerebroventricular (icv) administration of (5R)-(5 alpha, 7 alpha, 8 beta)-N-methyl-N-[7-(1-pyrrolindinyl)-1-…”
    Get more information
    Journal Article
  9. 9

    The antinociceptive action of supraspinal opioids results from an increase in descending inhibitory control: correlation of nociceptive behavior and c-fos expression by Gogas, K R, Presley, R W, Levine, J D, Basbaum, A I

    Published in Neuroscience (1991)
    “…In an earlier report, we demonstrated that subcutaneous injection of formalin in the rat hindpaw evokes a characteristic pattern of expression of the fos…”
    Get more information
    Journal Article
  10. 10

    Diffuse noxious inhibitory controls reduce the expression of noxious stimulus-evoked Fos-like immunoreactivity in the superficial and deep laminae of the rat spinal cord by Morgan, M M, Gogas, K R, Basbaum, A I

    Published in Pain (Amsterdam) (01-03-1994)
    “…Behavioral and electrophysiological studies have shown that a noxious stimulus applied to one part of the body can reduce the response to a subsequent noxious…”
    Get more information
    Journal Article
  11. 11

    Distribution of the Tetrodotoxin-Resistant Sodium Channel PN3 in Rat Sensory Neurons in Normal and Neuropathic Conditions by Novakovic, Sanja D, Tzoumaka, Elda, McGivern, Joseph G, Haraguchi, Miki, Sangameswaran, Lakshmi, Gogas, Kathleen R, Eglen, Richard M, Hunter, John C

    Published in The Journal of neuroscience (15-03-1998)
    “…The novel sodium channel PN3/alpha-SNS, which was cloned from a rat dorsal root ganglion (DRG) cDNA library, is expressed predominantly in small sensory…”
    Get full text
    Journal Article
  12. 12

    A role for histamine and H2-receptors in opioid antinociception by Gogas, K R, Hough, L B, Eberle, N B, Lyon, R A, Glick, S D, Ward, S J, Young, R C, Parsons, M E

    “…To investigate the role of brain H2-receptors in opioid antinociceptive mechanisms, the effects of several antagonists of histamine H2-receptors were…”
    Get more information
    Journal Article
  13. 13

    Inhibition of naloxone-resistant antinociception by centrally administered H2-antagonists by Gogas, K R, Hough, L B

    “…In order to test directly the hypothesis that brain histamine and H2-receptors mediate the naloxone-resistant footshock-induced antinociception (FSIA) elicited…”
    Get more information
    Journal Article
  14. 14

    Effects of zolantidine a brain-penetrating H2-receptor antagonist, on naloxone-sensitive and naloxone-resistant analgesia by Gogas, K R, Hough, L B

    Published in Neuropharmacology (01-04-1988)
    “…The action of zolantidine, a histamine H2-receptor antagonist which penetrates the brain, was characterized on the analgesia elicited by brief continuous…”
    Get more information
    Journal Article
  15. 15

    Cross-tolerance and cross-sensitization between morphine analgesia and naloxone-sensitive and cimetidine-sensitive stress-induced analgesia by Weinstein, I J, Hough, L B, Gogas, K R

    “…Recent studies have shown that different regimens of footshock elicit either "opiate" (naloxone-sensitive) or "histaminergic" (cimetidine-sensitive but…”
    Get more information
    Journal Article
  16. 16

    H2-receptor-mediated stress-induced analgesia is dependent on neither pituitary nor adrenal activation by Gogas, K R, Hough, L B

    Published in Pharmacology, biochemistry and behavior (01-07-1988)
    “…The effects of hypophysectomy and adrenalectomy were studied on the analgesia elicited by a 3 min exposure to 3.5 mA of continuous inescapable footshock, a…”
    Get more information
    Journal Article
  17. 17

    Opposing actions of cimetidine on naloxone-sensitive and naloxone-insensitive forms of footshock-induced analgesia by Gogas, K R, Hough, L B, Glick, S D, Su, K

    Published in Brain research (09-04-1986)
    “…The effects of the opiate antagonist naloxone (10 mg/kg) and the histamine H2-antagonist cimetidine (100 mg/kg; both administered i.p.) were studied on the…”
    Get more information
    Journal Article
  18. 18

    Actions of the brain-penetrating H2-antagonist zolantidine on histamine dynamics and metabolism in rat brain by Hough, L B, Jackowski, S, Eberle, N, Gogas, K R, Camarota, N A, Cue, D

    Published in Biochemical pharmacology (15-12-1988)
    “…The effects of zolantidine, the first brain-penetrating H2-receptor antagonist, on the brain levels of histamine (HA) and the HA metabolite…”
    Get more information
    Journal Article
  19. 19
  20. 20